When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. FTC alleges PBMs cost consumers $7.3 billion marking up drug ...

    www.aol.com/finance/ftc-releases-second-report...

    The FTC released a 60-page report Tuesday targeting the biggest three pharmacy benefit managers, claiming the companies hiked the prices of specialty drugs to generate $7.3 billion in revenue from ...

  3. Federal Trade Commission sues largest drug middlemen for ...

    www.aol.com/federal-trade-commission-sues...

    Prior FTC inquiry. Friday’s action comes a little more than two months after the FTC published a scathing interim report on the PBM industry that followed a two-year inquiry. It detailed how ...

  4. US FTC to sue drug middlemen over insulin prices, source says

    www.aol.com/news/us-ftc-sue-drug-middlemen...

    (Reuters) -The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health over their tactics as middlemen in negotiating prices for drugs including insulin, a person ...

  5. Pharmacy benefit management - Wikipedia

    en.wikipedia.org/wiki/Pharmacy_benefit_management

    The logo for CVS Caremark, one of the three largest PBM companies in the US. In 2011 Caremark Rx was the nation's second-largest PBM. Caremark Rx was subject to a class action lawsuit in Tennessee, which alleged that Caremark kept discounts from drug manufacturers instead of sharing them with member benefit plans, secretly negotiated rebates ...

  6. UnitedHealth, employer of slain exec Brian Thompson ... - AOL

    www.aol.com/finance/unitedhealth-employer-slain...

    UnitedHealth’s OptumRx told Fortune it is still reviewing the specifics of the report, but the PBM said it helped eligible patients save $1.3 billion in costs, estimating the median out-of ...

  7. PBMs made billions marking up specialty drugs by more than ...

    www.aol.com/news/pbms-made-billions-marking...

    The FTC found that 22 percent of specialty drugs dispensed by PBM-affiliated pharmacies were marked up by more than 1,000 percent while 41 percent were marked up between 100 and 1,000 percent.

  8. List of off-label promotion pharmaceutical settlements

    en.wikipedia.org/wiki/List_of_off-label...

    The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...

  9. Axon Enterprise, Inc. v. Federal Trade Commission - Wikipedia

    en.wikipedia.org/wiki/Axon_Enterprise,_Inc._v...

    The company offered to settle, but the FTC declined. In January 2020, Axon filed a lawsuit in the United States District Court for the District of Arizona, challenging the constitutionality of FTC's structure. The district court dismissed the case, holding that federal law stripped it of jurisdiction to consider constitutional claims against ...